Cargando…

Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes

Urinary albumin excretion is an early sign of diabetic kidney disease, affecting every third individual with diabetes. Despite substantial estimated heritability, only variants in the GLRA3 gene have been genome-wide significantly associated (p-value < 5 × 10(−8)) with diabetic albuminuria, in Fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandholm, Niina, Haukka, Jani K, Toppila, Iiro, Valo, Erkka, Harjutsalo, Valma, Forsblom, Carol, Groop, Per-Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098108/
https://www.ncbi.nlm.nih.gov/pubmed/30120300
http://dx.doi.org/10.1038/s41598-018-29211-1
_version_ 1783348406122446848
author Sandholm, Niina
Haukka, Jani K
Toppila, Iiro
Valo, Erkka
Harjutsalo, Valma
Forsblom, Carol
Groop, Per-Henrik
author_facet Sandholm, Niina
Haukka, Jani K
Toppila, Iiro
Valo, Erkka
Harjutsalo, Valma
Forsblom, Carol
Groop, Per-Henrik
author_sort Sandholm, Niina
collection PubMed
description Urinary albumin excretion is an early sign of diabetic kidney disease, affecting every third individual with diabetes. Despite substantial estimated heritability, only variants in the GLRA3 gene have been genome-wide significantly associated (p-value < 5 × 10(−8)) with diabetic albuminuria, in Finnish individuals with type 1 diabetes; However, replication attempt in non-Finnish Europeans with type 1 diabetes showed nominally significant association in the opposite direction, suggesting a population-specific effect, but simultaneously leaving the finding controversial. In this study, the association between the common rs10011025 variant in the GLRA3 locus, and albuminuria, was confirmed in 1259 independent Finnish individuals with type 1 diabetes (p = 0.0013), and meta-analysis of all Finnish individuals yielded a genome-wide significant association. The association was particularly pronounced in subjects not reaching the treatment target for blood glucose levels (HbA(1c) > 7%; N = 2560, p = 1.7 × 10(−9)). Even though further studies are needed to pinpoint the causal variants, dissecting the association at the GLRA3 locus may uncover novel molecular mechanisms for diabetic albuminuria irrespective of population background.
format Online
Article
Text
id pubmed-6098108
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60981082018-08-23 Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes Sandholm, Niina Haukka, Jani K Toppila, Iiro Valo, Erkka Harjutsalo, Valma Forsblom, Carol Groop, Per-Henrik Sci Rep Article Urinary albumin excretion is an early sign of diabetic kidney disease, affecting every third individual with diabetes. Despite substantial estimated heritability, only variants in the GLRA3 gene have been genome-wide significantly associated (p-value < 5 × 10(−8)) with diabetic albuminuria, in Finnish individuals with type 1 diabetes; However, replication attempt in non-Finnish Europeans with type 1 diabetes showed nominally significant association in the opposite direction, suggesting a population-specific effect, but simultaneously leaving the finding controversial. In this study, the association between the common rs10011025 variant in the GLRA3 locus, and albuminuria, was confirmed in 1259 independent Finnish individuals with type 1 diabetes (p = 0.0013), and meta-analysis of all Finnish individuals yielded a genome-wide significant association. The association was particularly pronounced in subjects not reaching the treatment target for blood glucose levels (HbA(1c) > 7%; N = 2560, p = 1.7 × 10(−9)). Even though further studies are needed to pinpoint the causal variants, dissecting the association at the GLRA3 locus may uncover novel molecular mechanisms for diabetic albuminuria irrespective of population background. Nature Publishing Group UK 2018-08-17 /pmc/articles/PMC6098108/ /pubmed/30120300 http://dx.doi.org/10.1038/s41598-018-29211-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sandholm, Niina
Haukka, Jani K
Toppila, Iiro
Valo, Erkka
Harjutsalo, Valma
Forsblom, Carol
Groop, Per-Henrik
Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
title Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
title_full Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
title_fullStr Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
title_full_unstemmed Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
title_short Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes
title_sort confirmation of glra3 as a susceptibility locus for albuminuria in finnish patients with type 1 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098108/
https://www.ncbi.nlm.nih.gov/pubmed/30120300
http://dx.doi.org/10.1038/s41598-018-29211-1
work_keys_str_mv AT sandholmniina confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes
AT haukkajanik confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes
AT toppilaiiro confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes
AT valoerkka confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes
AT harjutsalovalma confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes
AT forsblomcarol confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes
AT groopperhenrik confirmationofglra3asasusceptibilitylocusforalbuminuriainfinnishpatientswithtype1diabetes